Clinical Trial Update: Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss [Phase 3]

View source ↗

Summary

Phase 3 trial of hydroxychloroquine for recurrent pregnancy loss is ongoing with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Recurrent Pregnancy Loss | Phase 3 | Status: UNKNOWN